STAT | Reporting from the frontiers of health and medicine Follow STAT+: Talawar bets bispecific approach can shake up eczema market Moderna still bullish on mRNA, Ipsen's acquisition of Kartos, and more biotech news from The Readout https://www.statnews.com/2026/06/29/biotech-news-talawar-bets-bispecific-approach-for-eczema/ statnews.com
